Phytochemicals as promising agents in Axl-targeted cancer treatment

ChuHee Lee1

  • 1Department of Biochemistry and Molecular Biology, School of Medicine, Yeungnam University, Daegu 42415, Korea.

Insights

Natural compounds show promise in inhibiting Axl receptor tyrosine kinase (RTK), a key factor in cancer progression and drug resistance. This review explores these natural Axl inhibitors for potential cancer therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Axl receptor tyrosine kinase (RTK) is crucial for cell survival, proliferation, migration, and immune response.
  • Axl dysregulation, including overexpression, drives tumor growth, metastasis, and chemotherapy resistance in various cancers.
  • Targeting Axl is a significant strategy for developing novel cancer treatments.

Purpose of the Study:

  • To provide a comprehensive review of natural compounds identified as Axl inhibitors.
  • To examine the mechanisms of action for these natural Axl inhibitors.
  • To discuss the therapeutic potential of natural compounds in Axl-targeted cancer therapy.

Main Methods:

  • Literature review of scientific databases for studies on natural compounds inhibiting Axl.
  • Analysis of identified natural compounds for their chemical structures and bioactivity.
  • Evaluation of reported mechanisms of Axl inhibition by these compounds.

Main Results:

  • Various natural compounds have demonstrated inhibitory effects against Axl.
  • These compounds exhibit diverse mechanisms for modulating Axl activity.
  • The identified natural compounds represent a promising source for developing Axl-targeted cancer drugs.

Conclusions:

  • Natural compounds offer a rich source of potential Axl inhibitors.
  • Further research into these compounds could lead to effective Axl-targeted cancer therapies.
  • Developing therapies based on natural Axl inhibitors may improve outcomes in Axl-dysregulated diseases.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K